Bladder cancer in women: when UTI symptoms need a second look

Blood in the urine is a bladder cancer red flag. In men, it triggers investigation. In women, it is often attributed to a urinary tract infection, treated with antibiotics, and managed as recurrent infection. By the time a cancer diagnosis is considered, the disease has frequently advanced beyond the stage where outcomes are best.

This week ABC Health reported on multiple women whose diagnoses were delayed by years — some who saw three or more clinicians before bladder cancer was considered. One woman was diagnosed with muscle-invasive disease after four years of presenting with what was treated as recurrent UTI. The common thread: bladder cancer is perceived as a disease of older men, so when a woman’s symptoms fit the picture, the prior probability sits low and the investigation is delayed.

The numbers matter

Bladder cancer is genuinely more common in men — about three in four Australian bladder cancer diagnoses are male. But women’s outcomes are worse. The five-year survival rate for women sits at around 50%, compared with almost 60% for men. That gap is attributed to stage at diagnosis: women are more likely to present with disease that has already invaded the muscle layer.

The five-year survival rate for bladder cancer has not improved since 1987 — running against the trend for most other cancers where earlier detection or improved treatment has shifted outcomes. Around 3,345 Australians were diagnosed last year.

Both-and: common symptoms, uncommon suspicion

The diagnostic challenge is structural, not a simple failure of attention. UTI symptoms — dysuria, frequency, urgency, haematuria — genuinely overlap with early bladder cancer presentations. UTIs are also far more common in women than in men, making UTI the correct first-line hypothesis in most cases. The base-rate maths are right.

The both-and: UTI is the more probable explanation for urinary symptoms in women, and bladder cancer is a real possibility that warrants consideration when those symptoms recur, fail to resolve, or include visible blood. The question is where the recurrence threshold sits, and whether it is being applied consistently.

Dr Magdalena Simonis, a GP and women’s health researcher at the University of Melbourne, names a practical threshold: more than two UTIs in six months, or more than three in a year, should prompt further investigation rather than repeat prescription. That is not an unusual symptom burden — it is a pattern many women have managed with serial antibiotics for years without a urine culture, cystoscopy, or urology referral entering the picture.

The other commonly dismissed finding is visible haematuria in the context of perimenopause. Urinary changes during perimenopause are real and well-documented — frequency, urgency and recurrent infections are part of genitourinary syndrome of menopause. But visible blood in the urine is not a feature of that syndrome, and attributing it to hormonal change without investigation delays a diagnosis that matters.

Risk factors that shift the probability

Smoking is the single largest modifiable risk factor for bladder cancer. A history of smoking — including past rather than current — substantially raises risk. A 49-year-old woman with recurrent dysuria and a 15 pack-year smoking history is not a low-risk presentation, even if she reads that way on the first consult.

Age also shifts the probability. Most bladder cancer cases occur over 55, but diagnoses do occur in the mid-forties. Other risk factors include prior cyclophosphamide exposure and prolonged occupational exposure to aromatic amines (historically in rubber, dye, textile and printing industries).

2 cents

The clinical ask here is narrow. It is not that every UTI presentation requires cystoscopy. It is:

Send a culture. Antibiotic prescribing for presumed UTI without a confirmed culture means the diagnosis was never confirmed. A negative culture opens the question.

Set a recurrence threshold. More than two UTIs in six months or three in a year should trigger a decision point: further investigation (urine cytology, renal tract ultrasound), a urology referral, or documented clinical reasoning for continuing conservative management.

Do not attribute visible haematuria to perimenopause. Genitourinary syndrome of menopause explains frequency, dryness and dyspareunia. It does not explain blood in the urine. When haematuria is in the picture, investigate it regardless of the hormonal context.

The systemic change — normalising investigation of urinary symptoms in women at the same threshold applied to men — is a longer policy project. The individual clinical response is available now.

Verdict: yes — the recurrence threshold and haematuria rule are practical, evidence-grounded, and apply to patients in any GP’s practice today.

---

Sources cited

1. Bladder cancer mistaken for UTI, perimenopause in women — ABC Health
2. Bladder cancer — Cancer Council Australia